3 - 7 December 2020

17th Global Cardio    ascular

Clinical Trialists Forum

C (2).png

We are looking forward to another successful CVCT Forum and are pleased to announce that the 2020 forum will be connecting with you virtually.

Our global community will come together via a state-of-the-art, virtual platform where we will continue to have open discussions and fruitful debates, which is at the heart of the CVCT forum.

3 - 7 Dec

ONLINE

3 - 7 December 2020

C (2).png

17th Global Cardio

ascular

Clinical Trialists Forum

CVCT+-+Jason+Dixson+Photography+-+113428

How can I (or my colleague) apply?

Please contact the chairs of CVCT

  • Pr Faiez Zannad

  • Dr Bertram Pitt

What Can the Fellowship Offer?

  • Work with Executive/Steering Committees and clinician scientists in Boehringer Ingelheim on CV outcome trial(s).

  • Undertake analyses of datasets that complements the fellow’s interest.

APPLICATION DEADLINE: January 31, 2021

Boehringer Ingelheim Fellowship Program

DVANCED FELLOWSHIP IN CV TRIALS

What problem are we trying to solve?

  • Without a steady supply of talent, innovation in outcome-based cardiovascular drug/device development is at risk.

  • Currently, there are only limited opportunities, if any, for clinical academics to gain expertise in the conduct of these global trials.

Why Boehringer Ingelheim?

  • Boehringer Ingelheim has a strong legacy of cardiovascular outcome trials, including EMPA-REG OUTCOME and Emperor-Reduced trials.

  • As a family-owned company, Boehringer Ingelheim plans in generations.

  • This partnership with CVCT is a unique opportunity to nurture future leaders in cardiovascular medicine.